Please login to the form below

Not currently logged in

Industry career survey 2009

Take part in PM's Industry Career Survey and play your part in compiling an authoritative and informed overview of current industry trends

Carys Mills logo

There is no denying the fact that the past year has been one with unprecedented challenges for pharma. Not only is there a global recession, but the industry is facing the end of the blockbluster era, patent expiries, restructuring and new communications challenges, to name a few. In order to keep abreast of these issues, as well as provide insight into their repercussions on individuals and the industry as a whole, we have restructured our traditional salary survey, to create the 2009 Industry Career Survey.

We anticipate that the results will prove fascinating reading; providing insight into the mechanisms being adopted to cope with the current business and economic pressures affecting pharma, as well as a clear understanding of stakeholders' attitudes towards these. Obviously, the greater the support for this survey, the more revealing and reflective its findings will be, so please take a few moments to complete the questionnaire in your October issue of Pharmaceutical Marketing, or complete the survey online. Look out for a downloadable pdf of the results in January on PMLiVE, as well as a discursive article in the January 2010 issue of Pharmaceutical Marketing, which will analyse the crucial trends. 


A charitable donation 
By completing the Industry Career Survey 2009, you have the chance to donate £250 to the charity of your choice. Through this action you could make a significant

difference by funding a bed in a hospice, rescuing a poorly treated animal, or helping research into a cause that is close to your heart – the choice is yours.

How to enterICM logo
To be entered into the prize draw, simply complete either the online or print survey (bound within this issue of Pharmaceutical Marketing). The survey is being processed by ICM Research. Your anonymity is completely assured.

At the beginning of the online survey, you will be asked to enter a six-letter codeword, together with your date of birth. This allows your entry to be included in the prize draw and will help us identify you as the winner.

The winning codeword will be published in the December 2009 issue of Pharmaceutical Marketing. If this code matches your code, then call us to claim your prize. You will be asked for your date of birth to validate your code.

So let's get started ... Simply fill in the printed questionnaire and return to the FREEPOST address, or complete the survey online

November 18, 2009: The 2009 survey has now closed. Thnak you for your participation.

Please note: Entries received after this date will not be entered into the prize draw. The results will be collated by ICM Research and published in the January 2010 issue of Pharmaceutical Marketing and on PMLiVE.

Good luck!

Rules and Regulations

• Only one entry per person is permitted
• Proof of posting will not be accepted as proof of delivery
• The prize must be accepted as offered: no cash alternative is available.


The industry career survey is sponsored by Carys Mills Recruitment and producted in association with ICM

13th October 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...